This debate is genuinely balanced on fundamentals but tilted toward the bear on the tactical setup. The bull is correct that AMD is a high-quality secular compounder — 50% revenue growth, 14pp gross margin expansion, 163% EPS growth in Q2 2026, $8.8B net cash, $8.84B TTM FCF, and a forward PEG of 1.02 are real and not in dispute. The fortress balance sheet and 200 SMA structure at $335.58 confirm the secular uptrend is intact. However, the bear wins the tactical argument decisively on four points: (1) Q2 FCF collapsed 39% sequentially despite revenue growth, with inventory +27% YoY and receivables +42% YoY — a real cash conversion warning; (2) the H2 EPS ramp math is aggressive, requiring $4.69/qtr average vs Q2's $1.38 print, putting the $15.45 consensus at meaningful revision risk; (3) technicals are unambiguously in distribution — below 10 EMA ($476.53), 50 SMA ($506.18, declining), and VWMA ($481.35), with the MACD line still deeply negative at -7.44 despite one session of marginal histogram improvement; and (4) the next 10 weeks have no positive catalysts while facing a hawkish Fed (89% no-cut probability), Broadcom's Q3 print on September 2, continued tariff headline risk, and ongoing institutional rotation (ARK's pivot into NVDA carries signal value beyond the $95M sizing). The bull's strongest counter — PEG of 1.0 is fair — argues against a Sell but does not argue for adding at $471 with an empty catalyst calendar and deteriorating flow picture. Fair valuation with negative momentum + hostile macro = asymmetric downside over the tactical horizon. The secular AI compute thesis remains intact but will not save AMD from near-term multiple compression in a higher-for-longer regime.

POSITION STRATEGY: Trim existing AMD exposure by 30-40% to reduce vulnerability to the asymmetric near-term setup. Maintain a core position (~60-70% of current weight) to preserve exposure to the intact secular AI thesis. Do not initiate or add to positions at current levels ($471).

RE-ADD TRIGGERS: (a) DEFENSIVE — Successful retest of the $451-456 zone (lower Bollinger Band + late-July consolidation floor) with a confirmed MACD bullish cross sustained 2-3 sessions and expanding volume; this would signal the base is forming. (b) MOMENTUM — Daily close above $506 (declining 50 SMA) with above-average volume and a sustained MACD line cross above zero; this would invalidate the distribution thesis. (c) FUNDAMENTAL — A pre-announcement or Q3 print that shows FCF recovery AND sequential inventory normalization, signaling that the cash conversion deterioration was transitory.

RISK MANAGEMENT: Place a hard stop on the remaining core position at $424 (below the late-July intraday low). A break below this level signals the consolidation has failed and opens downside toward the 200 SMA zone at $335-340 — a 28-29% drawdown from current levels that's well within AMD's 2.49 beta-adjusted risk profile. Use ATR ($25) for any tactical adjustments; avoid averaging down into a deteriorating setup.

CATALYST MONITORING: September 2 Broadcom Q3 print is a critical read on custom-silicon demand and AI capex digestion — a weak print would accelerate the bear case; track September FOMC for hawkish guidance confirmation (89% no-cut probability); watch for any pre-announcement signals from AMD or hyperscaler customers ahead of the November earnings.

HORIZON DISCIPLINE: This is a 4-12 week tactical view, not a secular call. Reassess at November Q3 earnings when the catalyst calendar resumes and the H2 EPS ramp gets its first real test. If AMD delivers in-line execution with FCF recovery, the Underweight can be reversed toward Hold or Overweight. If execution disappoints and EPS revisions accelerate lower, the position should be exited entirely (re-rating to Sell).

The investment plan makes a compelling tactical bear case despite acknowledging AMD's intact secular thesis. Four factors drive the trim recommendation: (1) Q2 FCF collapsed 39% sequentially with inventory +27% YoY and receivables +42% YoY — a genuine cash conversion warning; (2) the H2 EPS ramp to consensus $15.45 requires $4.69/qtr average vs Q2's $1.38 print, creating significant revision risk; (3) technicals show clear distribution — price below 10 EMA ($476.53), declining 50 SMA ($506.18), and MACD deeply negative at -7.44; and (4) the next 10 weeks lack positive catalysts while facing a hawkish Fed (89% no-cut probability), Broadcom's Q3 print on September 2, and ongoing institutional rotation (ARK's pivot to NVDA). Fair valuation (PEG 1.02) does not justify adding at $471 with an empty catalyst calendar and deteriorating flow picture. Action: trim 30-40% to neutralize asymmetric near-term risk while preserving core exposure to the AI compute thesis.

Stop loss: $424.00

Sizing: Trim 30-40% of current AMD exposure; maintain core position at 60-70% of current weight. Re-add only on confirmation: (a) defensive retest of $451-456 with MACD bullish cross, (b) momentum close above $506 with volume, or (c) FCF recovery + inventory normalization in Q3 print.